Showing results (211-220 of 275) with videos related to
Sort By:
Pageof 28
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.Gastroenterology|June 9, 2005
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapyJoseph J Y Sung, May-Ling Wong, Scott Bowden, et al.The Journal of General Virology|March 25, 2004
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype AFuminaka Sugauchi, Hiromitsu Kumada, Subrat A Acharya, et al.Journal of Hepatology|June 1, 2005
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year studyRobert G Gish, Huy Trinh, Nancy Leung, et al.AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.Antiviral Research|July 2, 2015
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intentRobert G Gish, Man-Fung Yuen, Henry Lik Yuen Chan, et al.Hepatology (Baltimore, Md.)|February 28, 2007
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisPaul J Pockros, Lennox Jeffers, Nezam Afdhal, et al.Pageof 28